UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Carcinogen found on some medicinal herbs
by Lee Han-soo
2017-09-21 11:32
Plastic surgeons’ group issues guideline for patient safety
by Lee Han-soo
2017-09-20 17:26
AI will be turning point in developing new drugs: report
by Lee Han-soo
2017-09-20 14:59
Samjin gets approval for phase 2 clinical trials for dry eye syndrome
by Lee Han-soo
2017-09-19 18:03
Samsung Bioepis gets nods for phase 3 trials to treat macular degeneration
by Lee Han-soo
2017-09-19 17:39
라인
Kuhnil Pharmaceuticals succeed in phase 3 clinical trial for Atorvastatin
by Lee Han-soo
2017-09-19 14:58
Samsung Medison presents ultrasonic diagnostic equipment results
by Lee Han-soo
2017-09-18 17:45
Genexin, Handok presents persistent growth hormone clinical trial results
by Lee Han-soo
2017-09-18 14:39
Celltrion in controversy over sexual harassment case
by Lee Han-soo
2017-09-15 18:11
Access Bio, PFSCM sign supply agreement for malaria kit
by Lee Han-soo
2017-09-15 14:52
라인
US agency okays new treatment for relapsed lymphatic cancer
by Lee Han-soo
2017-09-15 12:23
Huons to build new office
by Lee Han-soo
2017-09-15 10:29
‘BIOplus Incheon 2017’ shares product-developing know-how
by Lee Han-soo
2017-09-14 11:14
Sillajen stock surges upon clinical trial announcement
by Lee Han-soo
2017-09-12 13:26
Ildong, Olix agree to develop new drugs
by Lee Han-soo
2017-09-11 17:30
라인
Celltrion presents Herzuma’s clinical results in Europe
by Lee Han-soo
2017-09-11 12:19
Korea, Russia to cooperate on training medical workers
by Lee Han-soo
2017-09-08 17:43
Kang Stem, Heraeus Medical to develop anti-arthritis drug
by Lee Han-soo
2017-09-08 15:25
Vivus, Alvogen sign agreement to market diet treatment in Korea
by Lee Han-soo
2017-09-08 15:24
Celltrion fined for violating stock regulations
by Lee Han-soo
2017-09-07 18:16
-
이전
111
112
113
114
115
116
117
118
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top